BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22173044)

  • 1. Secretory phospholipase A2-mediated depletion of phosphatidylglycerol in early acute respiratory distress syndrome.
    Seeds MC; Grier BL; Suckling BN; Safta AM; Long DL; Waite BM; Morris PE; Hite RD
    Am J Med Sci; 2012 Jun; 343(6):446-51. PubMed ID: 22173044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction.
    Arbibe L; Koumanov K; Vial D; Rougeot C; Faure G; Havet N; Longacre S; Vargaftig BB; Béréziat G; Voelker DR; Wolf C; Touqui L
    J Clin Invest; 1998 Sep; 102(6):1152-60. PubMed ID: 9739049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant protein B inhibits secretory phospholipase A2 hydrolysis of surfactant phospholipids.
    Hite RD; Grier BL; Waite BM; Veldhuizen RA; Possmayer F; Yao LJ; Seeds MC
    Am J Physiol Lung Cell Mol Physiol; 2012 Jan; 302(2):L257-65. PubMed ID: 22037357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cooling on lung secretory phospholipase A2 activity in vitro, ex vivo, and in vivo.
    Autilio C; Shankar-Aguilera S; Minucci A; Touqui L; De Luca D
    Am J Physiol Lung Cell Mol Physiol; 2019 Mar; 316(3):L498-L505. PubMed ID: 30604626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acids cause secretory phospholipase A2 activity enhancement, revertible by exogenous surfactant administration.
    De Luca D; Minucci A; Zecca E; Piastra M; Pietrini D; Carnielli VP; Zuppi C; Tridente A; Conti G; Capoluongo ED
    Intensive Care Med; 2009 Feb; 35(2):321-6. PubMed ID: 18853138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo effect of varespladib on secretory phospholipase A2 alveolar activity in infants with ARDS.
    De Luca D; Minucci A; Piastra M; Cogo PE; Vendittelli F; Marzano L; Gentile L; Giardina B; Conti G; Capoluongo ED
    PLoS One; 2012; 7(10):e47066. PubMed ID: 23071714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfactant phospholipid changes after antigen challenge: a role for phosphatidylglycerol in dysfunction.
    Hite RD; Seeds MC; Bowton DL; Grier BL; Safta AM; Balkrishnan R; Waite BM; Bass DA
    Am J Physiol Lung Cell Mol Physiol; 2005 Apr; 288(4):L610-7. PubMed ID: 15347567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for phospholipase A2 in ARDS pathogenesis.
    Touqui L; Arbibe L
    Mol Med Today; 1999 Jun; 5(6):244-9. PubMed ID: 10366819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrolysis of surfactant-associated phosphatidylcholine by mammalian secretory phospholipases A2.
    Hite RD; Seeds MC; Jacinto RB; Balasubramanian R; Waite M; Bass D
    Am J Physiol; 1998 Oct; 275(4):L740-7. PubMed ID: 9755106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and biological role of secretory phospholipase A2 in acute respiratory distress syndrome infants.
    De Luca D; Lopez-Rodriguez E; Minucci A; Vendittelli F; Gentile L; Stival E; Conti G; Piastra M; Antonelli M; Echaide M; Perez-Gil J; Capoluongo ED
    Crit Care; 2013 Jul; 17(4):R163. PubMed ID: 23883784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretory Phospholipase A
    Papadopoulos S; Kazepidou E; Antonelou MH; Leondaritis G; Tsapinou A; Koulouras VP; Avgeropoulos A; Nakos G; Lekka ME
    Pharmaceuticals (Basel); 2020 Nov; 13(11):. PubMed ID: 33238426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol.
    Hallman M; Spragg R; Harrell JH; Moser KM; Gluck L
    J Clin Invest; 1982 Sep; 70(3):673-83. PubMed ID: 6896715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A specific phospholipase C activity regulates phosphatidylinositol levels in lung surfactant of patients with acute respiratory distress syndrome.
    Spyridakis S; Leondaritis G; Nakos G; Lekka ME; Galanopoulou D
    Am J Respir Cell Mol Biol; 2010 Mar; 42(3):357-62. PubMed ID: 19491339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS. Alterations in leukocytes, proteins, PAF and surfactant components.
    Nakos G; Kitsiouli EI; Tsangaris I; Lekka ME
    Intensive Care Med; 1998 Apr; 24(4):296-303. PubMed ID: 9609406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant-secreted phospholipase A
    De Luca D; Shankar-Aguilera S; Autilio C; Raschetti R; Vedovelli L; Fitting C; Payré C; Jeammet L; Perez-Gil J; Cogo PE; Carnielli VP; Lambeau G; Touqui L
    Am J Physiol Lung Cell Mol Physiol; 2020 Jul; 319(1):L95-L104. PubMed ID: 32401671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration.
    Schmidt R; Markart P; Ruppert C; Wygrecka M; Kuchenbuch T; Walmrath D; Seeger W; Guenther A
    Respir Res; 2007 Jul; 8(1):55. PubMed ID: 17662121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.
    Günther A; Siebert C; Schmidt R; Ziegler S; Grimminger F; Yabut M; Temmesfeld B; Walmrath D; Morr H; Seeger W
    Am J Respir Crit Care Med; 1996 Jan; 153(1):176-84. PubMed ID: 8542113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic time-window of a group IIA phospholipase A2 inhibitor in rabbit acute lung injury: correlation with lung surfactant protection.
    Furue S; Mikawa K; Nishina K; Shiga M; Ueno M; Tomita Y; Kuwabara K; Teshirogi I; Ono T; Hori Y; Matsukawa A; Yoshinaga M; Obara H
    Crit Care Med; 2001 Apr; 29(4):719-27. PubMed ID: 11373455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by pulmonary surfactant Curosurf of secretory phospholipase A2 expression in guinea-pig alveolar macrophages.
    Hidi R; Vial D; Havet N; Berger A; Vargaftig BB; Touqui L
    Biochem Pharmacol; 1997 Nov; 54(9):1055-8. PubMed ID: 9374427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant alteration and replacement in acute respiratory distress syndrome.
    Günther A; Ruppert C; Schmidt R; Markart P; Grimminger F; Walmrath D; Seeger W
    Respir Res; 2001; 2(6):353-64. PubMed ID: 11737935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.